Refresh

Bacil Pharma Ltd. - Research Center

524516 BACPHAR Group (XT) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income

Operating income

- - - - -
Expenses

Material consumed

- - - - -

Manufacturing expenses

- - - - -

Personnel expenses

0.10 0.09 0.06 0.05 0.09

Selling expenses

- - - - -

Adminstrative expenses

0.09 0.13 3.85 0.26 0.36

Expenses capitalised

- - - - -

Cost of sales

0.19 0.21 3.91 0.31 0.45

Operating profit

-0.19 -0.21 -3.91 -0.31 -0.45

Other recurring income

0.13 0.11 0.06 0.07 0.14

Adjusted PBDIT

-0.06 -0.10 -3.86 -0.23 -0.31

Financial expenses

- - - - -

Depreciation

- - - - 0.01

Other write offs

- - - - -

Adjusted PBT

-0.06 -0.10 -3.86 -0.24 -0.32

Tax charges

- - - - -

Adjusted PAT

-0.06 -0.10 -3.86 -0.24 -0.32

Non recurring items

- - - - -

Other non cash adjustments

- - - - -

Reported net profit

-0.06 -0.10 -3.86 -0.24 -0.32

Earnigs before appropriation

-5.31 -5.40 -9.00 -5.38 -4.93

Equity dividend

- - - - -

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

-5.31 -5.40 -9.00 -5.38 -4.93
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com